Identification of a rhodanine derivative BML-260 as a potent stimulator of UCP1 expression
Sign Up to like & getrecommendations! Published in 2019 at "Theranostics"
DOI: 10.7150/thno.31951
Abstract: Identification of proper agents to increase or activate UCP1+ cells in adipose tissues remains a potent therapeutic strategy to combat obesity. Screening systems for UCP1 activators have been previously established and allow for unbiased discovery… read more here.
Keywords: identification rhodanine; ucp1 expression; bml 260;